TY  - JOUR 
AU  - Toja Camba, Francisco Jose
AU  - García Quintanilla, Laura
AU  - Rodríguez Martínez, Lorena
AU  - Tomine, J.
AU  - Cajade-Pascual, F.
AU  - Feitosa, C.
AU  - Zarra Ferro, Irene
AU  - Barreiro de Acosta, Manuel
AU  - González-López, J.
AU  - Mondelo Garcia, Cristina
AU  - Fernández Ferreiro, Anxo
PY  - 2023
SN  - 1999-4923
UR  - http://hdl.handle.net/20.500.11940/21464
AB  - The introduction of point-of-care (POC) assays into clinical practice in patients with inflammatory disease enables on-demand therapeutic decision making. The aim of this study was to compare the POC test Quantum blue (Bühlmann Laboratories) for...
LA  - eng
TI  - Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies' Determination against ELISA
DO  - 10.3390/pharmaceutics15112615
T2  - Pharmaceutics
KW  - AS Santiago
KW  - CHUS
KW  - AS Santiago
KW  - CHUS
KW  - AS Santiago
KW  - IDIS
KW  - AS Santiago
KW  - CHUS
KW  - AS Santiago
KW  - CHUS
KW  - AS Santiago
KW  - CHUS
KW  - AS Santiago
KW  - CHUS
VL  - 15
ER  -